April 27, 2017 9:47 PM ET

Pharmaceuticals

Company Overview of Zevacor Pharma, Inc

Company Overview

Zevacor Pharma, Inc. develops, manufactures, and distributes PET and SPECT radiopharmaceuticals and provides associated educational services used in nuclear medicine and molecular imaging in the United States. The company offers cold kits and therapies, as well as accessories that include RadioAerosol delivery system; and Venticis, an aerosol generator intended for the study of pulmonary ventilation, study of alveolar-capillary permeability using radiopharmaceutical products labelled with technetium 99m. It also provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide helping them develop the next generation of molecular imagin...

21000 Atlantic Boulevard

Suite 730

Dulles, VA 20166

United States

Founded in 1986

Phone:

703-787-7900

Fax:

571-434-0330

Key Executives for Zevacor Pharma, Inc

Chief Executive Officer and President
Age: 42
President
Chief Operating Officer
Vice President of Human Resources
Senior Director of Business Development
Compensation as of Fiscal Year 2016.

Zevacor Pharma, Inc Key Developments

Actinium Pharmaceuticals, Inc. Enters into Agreement with Zevacor Pharma, Inc. for Good Manufacturing Practices, Manufacturing, Testing, Releasing and Distribution of Iomab-B For Pivotal Phase 3 Sierra Trial

Actinium Pharmaceuticals, Inc. announced that the company has entered into an agreement with Zevacor Pharma, Inc. for the clinical production and supply of Iomab-B for the upcoming pivotal Phase 3 SIERRA trial. Pursuant to the agreement, the company will perform the Good Manufacturing Practices, manufacturing, testing, releasing and distribution of Iomab-B for Actinium's pivotal Phase 3 SIERRA trial. Iomab-B is a radioimmunotherapy intended to be an induction and conditioning agent prior to a bone marrow transplant for Acute Myeloid Leukemia (AML) patients over the age of 55. Actinium's Iomab-B has received orphan drug designation from the U.S. Food and Drug Administration (FDA) and the pivotal Phase 3 SIERRA trial is expected to enroll 150 patients.

Zevacor Pharma, Inc. to Supply Gallium 68 DOTATATE

Zevacor Pharma, Inc. (fka IBA Molecular North America, Inc.) announced that it has been selected to supply Gallium 68 (Ga-68) DOTATATE doses prepared with a novel kit to U.S. hospitals and imaging centers for Advanced Accelerator Applications S.A. The kit has received orphan drug designation from the U.S. Food and Drug Administration. The FDA has also granted Priority Review to AAA’s New Drug Application (“NDA”) for the kit. The license application for the kit is currently under review by the FDA and the agreement between Zevacor and AAA is in anticipation of NDA approval.

Zevacor to Produce SomaKit-TATE Doses for AAA

Zevacor Pharma, Inc. (fka IBA Molecular North America, Inc.) announced that it has been selected to supply Gallium-68 (Ga-68) DOTATATE doses prepared with a novel kit to U.S. hospitals and imaging centers for Advanced Accelerator Applications S.A. SomaKit-TATE is a patented kit currently in development for the preparation of 68Ga-DOTATATE for injection, to help diagnose and manage somatostatin receptor-positive neuroendocrine tumor patients using Positron Emission Tomography (“PET”). The kit has received orphan drug designation from the U.S. Food and Drug Administration (“FDA”). The FDA has also granted Priority Review to AAA’s New Drug Application (“NDA”) for the kit. The license application for the kit is currently under review by the FDA and the agreement between Zevacor and AAA is in anticipation of NDA approval.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zevacor Pharma, Inc, please visit www.ibamolecular.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.